+1 858-523-8231
Login | Register
AA Blocks, Building Blocks, Catalysts, Inhibitors
Login | Register
Home Carboxes 942603-91-0
942603-91-0,MFCD34563581
Catalog No.:AA01XEN3

942603-91-0 | Ethyl 2-methylene-5-oxohexahydro-1H-pyrrolizine-7a-carboxylate

Pack Size
Purity
Availability
Price(USD)
Quantity
  
100mg
98%
in stock  
$24.00   $17.00
- +
250mg
98%
in stock  
$38.00   $27.00
- +
1g
95%
in stock  
$65.00   $46.00
- +
5g
95%
in stock  
$257.00   $180.00
- +
10g
95%
in stock  
$488.00   $342.00
- +
25g
95%
in stock  
$1,073.00   $751.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA01XEN3
Chemical Name:
Ethyl 2-methylene-5-oxohexahydro-1H-pyrrolizine-7a-carboxylate
CAS Number:
942603-91-0
Molecular Formula:
C11H15NO3
Molecular Weight:
209.2417
MDL Number:
MFCD34563581
SMILES:
CCOC(=O)C12CCC(=O)N2CC(=C)C1
Properties

Downstream Synthesis Route

[1]Masschelein,KurtG.R.;Stevens,ChristianV.;Dieltiens,Nicolai;Claeys,DiedericaD.[Tetrahedron,2007,vol.63,#22,p.4712-4724]

[2]CurrentPatentAssignee:MERCK&COINC-WO2015/77905,2015,A1Locationinpatent:Paragraph0172

[3]CurrentPatentAssignee:MERCK&COINC-WO2015/80988,2015,A1Locationinpatent:Paragraph0173

[4]CurrentPatentAssignee:INVENTISBIOCOLTD-WO2022/2102,2022,A1Locationinpatent:Paragraph204;206

[5]CurrentPatentAssignee:INVENTISBIOCOLTD-WO2022/42630,2022,A1Locationinpatent:Paragraph257

942603-91-0   
(2-methylenetetrahyro-1H-pyrrolizine-7a(5H)-yl)methanol 

[1]Masschelein,KurtG.R.;Stevens,ChristianV.;Dieltiens,Nicolai;Claeys,DiedericaD.[Tetrahedron,2007,vol.63,#22,p.4712-4724]

[2]CurrentPatentAssignee:MERCK&COINC-WO2015/77905,2015,A1Locationinpatent:Paragraph0173

[3]CurrentPatentAssignee:MERCK&COINC-WO2015/80988,2015,A1Locationinpatent:Paragraph0173

942603-91-0   
ethyl2,5-dioxotetrahydro-1H-pyrrolizine-7a(5H)-carboxylate 

[1]Roecker,AnthonyJ.;Egbertson,Melissa;Jones,KristenL.G.;Gomez,Robert;Kraus,RichardL.;Li,Yuxing;Koser,AmyJo;Urban,MarkO.;Klein,Rebecca;Clements,Michelle;Panigel,Jacqueline;Daley,Christopher;Wang,Jixin;Finger,EleftheriaN.;Majercak,John;Santarelli,Vincent;Gregan,Irene;Cato,Matthew;Filzen,Tracey;Jovanovska,Aneta;Wang,Ying-Hong;Wang,Deping;Joyce,LeoA.;Sherer,EdwardC.;Peng,Xuanjia;Wang,Xiu;Sun,Haiyan;Coleman,PaulJ.;Houghton,AndreaK.;Layton,MarkE.[BioorganicandMedicinalChemistryLetters,2017,vol.27,#10,p.2087-2093]

[2]Masschelein,KurtG.R.;Stevens,ChristianV.;Dieltiens,Nicolai;Claeys,DiedericaD.[Tetrahedron,2007,vol.63,#22,p.4712-4724]

[3]CurrentPatentAssignee:MERCK&COINC-WO2015/77905,2015,A1Locationinpatent:Paragraph0187;0223

[4]CurrentPatentAssignee:MERCK&COINC-WO2015/80988,2015,A1Locationinpatent:Paragraph0187

[5]CurrentPatentAssignee:PFIZERINC-WO2020/146613,2020,A1Locationinpatent:Paragraph0362

[6]CurrentPatentAssignee:PFIZERINC;MIRATITHERAPEUTICS,INC.-WO2021/41671,2021,A1Locationinpatent:Paragraph0259;0509

[7]CurrentPatentAssignee:INVENTISBIOCOLTD-WO2022/2102,2022,A1Locationinpatent:Paragraph204;207

[8]CurrentPatentAssignee:PFIZERINC;MIRATITHERAPEUTICS,INC.-WO2022/31678,2022,A1Locationinpatent:Paragraph0195

[9]CurrentPatentAssignee:PFIZERINC;MIRATITHERAPEUTICS,INC.-WO2022/31678,2022,A1Locationinpatent:Paragraph0195

[10]CurrentPatentAssignee:MIRATITHERAPEUTICS,INC.;PFIZERINC-WO2022/66646,2022,A1Locationinpatent:Paragraph00231;00234

[11]CurrentPatentAssignee:MIRATITHERAPEUTICS,INC.;PFIZERINC-WO2022/66646,2022,A1Locationinpatent:Paragraph00246;00248

[12]CurrentPatentAssignee:INVENTISBIOCOLTD-WO2022/42630,2022,A1Locationinpatent:Paragraph258

[13]CurrentPatentAssignee:PFIZERINC;MIRATITHERAPEUTICS,INC.-WO2022/98625,2022,A1Locationinpatent:Paragraph0147

1-tert-butyl2-ethyl5-oxopyrrolidine-1,2-dicarboxylate 
  942603-91-0 

[1]Masschelein,KurtG.R.;Stevens,ChristianV.;Dieltiens,Nicolai;Claeys,DiedericaD.[Tetrahedron,2007,vol.63,#22,p.4712-4724]

[2]CurrentPatentAssignee:MERCK&COINC-WO2015/77905,2015,A1

[3]CurrentPatentAssignee:MERCK&COINC-WO2015/80988,2015,A1

[4]CurrentPatentAssignee:INVENTISBIOCOLTD-WO2022/2102,2022,A1

[5]CurrentPatentAssignee:INVENTISBIOCOLTD-WO2022/42630,2022,A1

[1]CurrentPatentAssignee:MIRATITHERAPEUTICS,INC.;PFIZERINC-WO2022/66646,2022,A1Locationinpatent:Paragraph00246-00247

[2]CurrentPatentAssignee:MERCK&COINC-WO2015/77905,2015,A1

[3]CurrentPatentAssignee:MERCK&COINC-WO2015/80988,2015,A1

[4]CurrentPatentAssignee:INVENTISBIOCOLTD-WO2022/2102,2022,A1

[5]CurrentPatentAssignee:INVENTISBIOCOLTD-WO2022/42630,2022,A1

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 942603-91-0
Building Blocks
More >
Tags:942603-91-0 Molecular Formula|942603-91-0 MDL|942603-91-0 SMILES|942603-91-0 Ethyl 2-methylene-5-oxohexahydro-1H-pyrrolizine-7a-carboxylate